# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Multiple sclerosis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 471-480 of 487 results.
Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
Status: Recruiting
Last Changed: Aug 28, 2020
First Received: May 09, 2019
Disease(s): Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury, Chronic Pain Due to Trauma, Fibromyalgia, Seizures, Hepatitis C, Cancer, Crohn Disease, HIV/AIDS, Multiple Sclerosis, Traumatic Brain Injury, Sickle Cell Disease, Post Traumatic Stress Disorder, Tourette Syndrome, Ulcerative Colitis, Glaucoma, Epilepsy, Inflammatory Bowel Diseases, Parkinson Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy, Anxiety, Depression, Insomnia, Autism, Opioid-use Disorder, Bipolar Disorder, Covid19, SARS-CoV Infection, COVID-19, Corona Virus Infection, Coronavirus
Intervention(s): Cannabis, Medical
Locations: OMNI Medical Services, Boca Raton, Florida, United States
OMNI Medical Services, Bradenton, Florida, United States
OMNI Medical Services, Fort Lauderdale, Florida, United States
OMNI Medical Services, Fort Myers, Florida, United States
OMNI Medical Services, Gainesville, Florida, United States
... and 13 other locations.
Safety and Efficacy of Fecal Microbiota Transplantation
Status: Recruiting
Last Changed: Apr 22, 2020
First Received: Jul 10, 2019
Disease(s): Crohn Disease, Ulcerative Colitis, Celiac Disease, Irritable Bowel Syndrome, Functional Dysphonia, Constipation, Clostridium Difficile Infection, Diabetes Mellitus, Obesity, Multidrug -Resistant Infection, Hepatic Encephalopathy, Multiple Sclerosis, Pseudo-Obstruction, Carbapenem-Resistant Enterobacteriaceae Infection, Vancomycin Resistant Enterococci Infection, Multiple Organ Dysfunction Syndrome, Dysbiotic Bowel Syndrome, MRSA Enteritis, Pseudomembranous Enterocolitis, Alopecia, Autism, Graft-versus-host Disease, Idiopathic Thrombocytopenic Purpura, Atopy or Allergy, Liver Disease, Alcohol Dependence, Psoriatic Arthropathy
Intervention(s): Fecal Microbiota Transplantation
Locations: The Chinese University of Hong Kong, Hong Kong, Shatin, Hong Kong
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Status: Recruiting
Last Changed: Apr 03, 2020
First Received: Mar 13, 2020
Disease(s): Chronic Pancreatitis, Inflammatory Bowel Diseases, Hepatitis, NASH - Nonalcoholic Steatohepatitis, Acute Pancreatitis, Rheumatoid Arthritis, Diabetes Mellitus, Dyslipidemias, Multiple Sclerosis, Irritable Bowel Syndrome, Chronic Pain, Chronic Disease, Chronic Kidney Diseases, Crohn Disease, Celiac Disease, Biliary Cirrhosis, Bile Acid Synthesis Defect, Gastritis, Cholecystitis, Cholelithiases, IPMN, Cyst Pancreas, Cystic Fibrosis, Pancreatic Exocrine Insufficiency, Diarrhea Chronic, Constipation - Functional, Constipation Chronic Idiopathic
Intervention(s): venipuncture, Questionnaires, Additional Sample Collections
Locations: University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions in Alopecia Areata
Status: Not yet recruiting
Last Changed: Jan 28, 2020
First Received: Jan 27, 2020
Disease(s): Alopecia Areata, Depressive Episode, Recurrent Depressive Disorder, Anxiety Disorders, Atopic Dermatitis, Allergic Rhinitis, Asthma, Crohn Disease, Ulcerative Colitis, Pernicious Anemia, Type 1 Diabetes, Hashimoto Thyroiditis, Graves Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Polymyalgia Rheumatica, Sjogren's Syndrome, Psoriasis, Vitiligo, Multiple Sclerosis, Celiac Disease
Intervention(s): Exposure of interest (studies 2 & 3).
Locations: Momentum Data Ltd, London, United Kingdom
Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis
Status: Recruiting
Last Changed: Jan 14, 2020
First Received: May 30, 2018
Disease(s): Sclerosis, Multiple, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Autoimmune Diseases
Intervention(s): Melatonin, Placebo
Locations: Virgen Macarena Hospital, Seville, Spain
Hospital Vithas Nisa Sevilla, Seville, Spain
Fampridine-SR and Optic Neuritis Recovery
Status: Not yet recruiting
Last Changed: Nov 04, 2019
First Received: Nov 04, 2019
Disease(s): Optic Neuritis
Intervention(s): Fampridine SR
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
Status: Recruiting
Last Changed: Feb 28, 2020
First Received: Aug 13, 2015
Disease(s): Optic Neuritis
Intervention(s): Clemastine, Placebo
Locations: University of California San Francisco, San Francisco, California, United States
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Status: Recruiting
Last Changed: May 11, 2020
First Received: Nov 21, 2012
Disease(s): Progressive Multifocal Leukoencephalopathy
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Periodic Leg Movements' Diagnosis in Spinal Cord Injury: Actigraphy as an Alternative for Polysomnography?
Status: Not yet recruiting
Last Changed: Nov 06, 2020
First Received: Nov 06, 2020
Disease(s): Spinal Cord Injuries, Periodic Limb Movement Disorder
Intervention(s): PSG and actigraphy recording
Locations: Physiologie, explorations fonctionnelles - Unité des pathologies du sommeil, Hôpital Raymond Poincaré, APHP, Garches, France
Repetitive Transorbital Alternating Current Stimulation in Acute Autoimmune Optic Neuritis
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Mar 05, 2019
Disease(s): Acute Autoimmune Inflammatory Optic Neuritis
Intervention(s): active-rtACS treatment, sham-rtACS treatment
Locations: Department of Neurology and Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland